148 related articles for article (PubMed ID: 36331258)
1. Neutrophils as immune effector cells in antibody therapy in cancer.
Behrens LM; van Egmond M; van den Berg TK
Immunol Rev; 2023 Mar; 314(1):280-301. PubMed ID: 36331258
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis.
Matlung HL; Babes L; Zhao XW; van Houdt M; Treffers LW; van Rees DJ; Franke K; Schornagel K; Verkuijlen P; Janssen H; Halonen P; Lieftink C; Beijersbergen RL; Leusen JHW; Boelens JJ; Kuhnle I; van der Werff Ten Bosch J; Seeger K; Rutella S; Pagliara D; Matozaki T; Suzuki E; Menke-van der Houven van Oordt CW; van Bruggen R; Roos D; van Lier RAW; Kuijpers TW; Kubes P; van den Berg TK
Cell Rep; 2018 Jun; 23(13):3946-3959.e6. PubMed ID: 29949776
[TBL] [Abstract][Full Text] [Related]
3. Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Brandsma AM; Bondza S; Evers M; Koutstaal R; Nederend M; Jansen JHM; Rösner T; Valerius T; Leusen JHW; Ten Broeke T
Front Immunol; 2019; 10():704. PubMed ID: 31031746
[TBL] [Abstract][Full Text] [Related]
4. Myeloid cells as effector cells for monoclonal antibody therapy of cancer.
Braster R; O'Toole T; van Egmond M
Methods; 2014 Jan; 65(1):28-37. PubMed ID: 23811299
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo.
Li B; Xu L; Tao F; Xie K; Wu Z; Li Y; Li J; Chen K; Pi C; Mendelsohn A; Larrick JW; Gu H; Fang J
Oncotarget; 2017 Jun; 8(24):39356-39366. PubMed ID: 28454118
[TBL] [Abstract][Full Text] [Related]
6. G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment.
Martinez Sanz P; van Rees DJ; van Zogchel LMJ; Klein B; Bouti P; Olsman H; Schornagel K; Kok I; Sunak A; Leeuwenburg K; Timmerman I; Dierselhuis MP; Kholosy WM; Molenaar JJ; van Bruggen R; van den Berg TK; Kuijpers TW; Matlung HL; Tytgat GAM; Franke K
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049929
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.
Borrok MJ; Luheshi NM; Beyaz N; Davies GC; Legg JW; Wu H; Dall'Acqua WF; Tsui P
MAbs; 2015; 7(4):743-51. PubMed ID: 25970007
[TBL] [Abstract][Full Text] [Related]
8. FcalphaRI (CD89) as a novel trigger molecule for bispecific antibody therapy.
Valerius T; Stockmeyer B; van Spriel AB; Graziano RF; van den Herik-Oudijk IE; Repp R; Deo YM; Lund J; Kalden JR; Gramatzki M; van de Winkel JG
Blood; 1997 Dec; 90(11):4485-92. PubMed ID: 9373259
[TBL] [Abstract][Full Text] [Related]
9. FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
Treffers LW; van Houdt M; Bruggeman CW; Heineke MH; Zhao XW; van der Heijden J; Nagelkerke SQ; Verkuijlen PJJH; Geissler J; Lissenberg-Thunnissen S; Valerius T; Peipp M; Franke K; van Bruggen R; Kuijpers TW; van Egmond M; Vidarsson G; Matlung HL; van den Berg TK
Front Immunol; 2018; 9():3124. PubMed ID: 30761158
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte-colony stimulating factor enhances chimeric antibody Nd2 dependent cytotoxicity against pancreatic cancer mediated by polymorphonuclear neutrophils.
Tamamori Y; Sawada T; Nishihara T; Yamashita Y; Ohira M; Ho JJ; Kim YS; Hirakawa-Y S Chung K
Int J Oncol; 2002 Sep; 21(3):649-54. PubMed ID: 12168113
[TBL] [Abstract][Full Text] [Related]
11. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy.
Hubert P; Heitzmann A; Viel S; Nicolas A; Sastre-Garau X; Oppezzo P; Pritsch O; Osinaga E; Amigorena S
Cancer Res; 2011 Aug; 71(15):5134-43. PubMed ID: 21697279
[TBL] [Abstract][Full Text] [Related]
12. IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition.
Treffers LW; Ten Broeke T; Rösner T; Jansen JHM; van Houdt M; Kahle S; Schornagel K; Verkuijlen PJJH; Prins JM; Franke K; Kuijpers TW; van den Berg TK; Valerius T; Leusen JHW; Matlung HL
Cancer Immunol Res; 2020 Jan; 8(1):120-130. PubMed ID: 31690649
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic exploitation of neutrophils to fight cancer.
Gruijs M; Sewnath CAN; van Egmond M
Semin Immunol; 2021 Oct; 57():101581. PubMed ID: 34922817
[TBL] [Abstract][Full Text] [Related]
14. Cancer cells resist antibody-mediated destruction by neutrophils through activation of the exocyst complex.
van Rees DJ; Bouti P; Klein B; Verkuijlen PJH; van Houdt M; Schornagel K; Tool ATJ; Venet D; Sotiriou C; El-Abed S; Izquierdo M; Guillaume S; Saura C; Di Cosimo S; Huober J; Roylance R; Kim SB; Kuijpers TW; van Bruggen R; van den Berg TK; Matlung HL
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35728876
[TBL] [Abstract][Full Text] [Related]
15. Role of FcγRs in Antibody-Based Cancer Therapy.
Graziano RF; Engelhardt JJ
Curr Top Microbiol Immunol; 2019; 423():13-34. PubMed ID: 30790079
[TBL] [Abstract][Full Text] [Related]
16. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies.
Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T
Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699
[TBL] [Abstract][Full Text] [Related]
17. Neutrophils as effector cells for antibody-based immunotherapy of cancer.
van Egmond M; Bakema JE
Semin Cancer Biol; 2013 Jun; 23(3):190-9. PubMed ID: 23287459
[TBL] [Abstract][Full Text] [Related]
18. The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements.
Graziano RF; Erbe DV; Fanger MW
J Immunol; 1989 Dec; 143(12):3894-900. PubMed ID: 2574205
[TBL] [Abstract][Full Text] [Related]
19. Fc receptor-dependent mechanisms of monoclonal antibody therapy of cancer.
Bakema JE; van Egmond M
Curr Top Microbiol Immunol; 2014; 382():373-92. PubMed ID: 25116109
[TBL] [Abstract][Full Text] [Related]
20. Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody.
Zhang D; Goldberg MV; Chiu ML
J Biol Chem; 2016 Dec; 291(53):27134-27146. PubMed ID: 27856634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
